[HTML][HTML] Pegylated liposomal doxorubicin-related palmar-plantar erythrodysesthesia ('hand-foot'syndrome)

D Lorusso, A Di Stefano, V Carone, A Fagotti… - Annals of …, 2007 - Elsevier
Abstract Palmar-plantar erythrodysesthesia (PPE), also called hand-foot syndrome or hand-
to-foot syndrome, is a distinctive and relatively frequent dermatologic toxic reaction …

ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma

…, J Ledermann, T Bosse, C Chargari, A Fagotti… - International Journal of …, 2021 - ijgc.bmj.com
A European consensus conference on endometrial carcinoma was held in 2014 to produce
multi-disciplinary evidence-based guidelines on selected questions. Given the large body of …

Chemotherapy resistance in epithelial ovarian cancer: Mechanisms and emerging treatments

…, G Corrado, C Ricci, G Scambia, A Fagotti - Seminars in Cancer …, 2021 - Elsevier
Ovarian cancer (OC) remains a fatal malignancy because most patients experience
recurrent disease, which is resistant to chemotherapy. The outcomes for patients with …

[HTML][HTML] Pathological chemotherapy response score is prognostic in tubo-ovarian high-grade serous carcinoma: a systematic review and meta-analysis of individual …

…, MJ Devlin, HM Ditzel, E Drecoll, T Ebata, A Fagotti… - Gynecologic …, 2019 - Elsevier
Objective There is a need to develop and validate biomarkers for treatment response and
survival in tubo-ovarian high-grade serous carcinoma (HGSC). The chemotherapy response …

[HTML][HTML] Effect of COVID-19 pandemic lockdowns on planned cancer surgery for 15 tumour types in 61 countries: an international, prospective, cohort study

…, T Khan, L Chiva, J Sehouli, A Fagotti… - The Lancet …, 2021 - thelancet.com
Background Surgery is the main modality of cure for solid cancers and was prioritised to
continue during COVID-19 outbreaks. This study aimed to identify immediate areas for …

A laparoscopy-based score to predict surgical outcome in patients with advanced ovarian carcinoma: a pilot study

A Fagotti, G Ferrandina, F Fanfani, A Ercoli… - Annals of surgical …, 2006 - Springer
Background Our objective was to set up a more objective quantitative laparoscopy-based
model in predicting the chances of optimal cytoreductive surgery in advanced ovarian …

[HTML][HTML] Phase III randomised clinical trial comparing primary surgery versus neoadjuvant chemotherapy in advanced epithelial ovarian cancer with high tumour load …

A Fagotti, G Ferrandina, G Vizzielli, F Fanfani… - European journal of …, 2016 - Elsevier
Objective To establishing whether neoadjuvant chemotherapy (NACT) followed by interval
debulking surgery (IDS) is superior primary debulking surgery (PDS) in terms of clinical …

Randomized trial of primary debulking surgery versus neoadjuvant chemotherapy for advanced epithelial ovarian cancer (SCORPION-NCT01461850)

A Fagotti, MG Ferrandina, G Vizzielli… - International Journal of …, 2020 - ijgc.bmj.com
Objective To investigate whether neoadjuvant chemotherapy followed by interval debulking
surgery is superior to primary debulking surgery in terms of perioperative complications and …

Prospective validation of a laparoscopic predictive model for optimal cytoreduction in advanced ovarian carcinoma

A Fagotti, G Ferrandina, F Fanfani, G Garganese… - American journal of …, 2008 - Elsevier
OBJECTIVE: The purpose of this study was to validate the performance of a laparoscopy-
based model to predict optimal cytoreduction in advanced ovarian cancer patients. STUDY …

COVID-19 global pandemic: options for management of gynecologic cancers

…, AGZ Eriksson, M Frumovitz, A Fagotti… - Obstetrical & …, 2020 - journals.lww.com
In the midst of this devastating pandemic associated with the novel coronavirus 2019
(COVID-19) disease, we must continue to provide high-value care to patients with chronic …